Roche spends $1 billion on Foundation Medicine's tumor profiling.
Mark
M
Ratner
D023281:Genomics / Q000191:economics*; D006801:Humans; D007753:Laboratories / Q000191:economics*; D009369:Neoplasms / Q000191:economics* / Q000235:genetics*; D057285:Precision Medicine / Q000191:economics; D012106:Research / Q000191:economics